Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.91 USD | +5.68% | +7.14% | -4.30% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
Evolution of the average Target Price on Harmony Biosciences Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Harmony Biosciences Holdings, Inc.
Mizuho Securities | |
Needham & Co. | |
Goldman Sachs | |
BofA Securities | |
Raymond James | |
Berenberg Bank | |
Cantor Fitzgerald | |
Piper Sandler | |
Jefferies & Co. | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- HRMY Stock
- Consensus Harmony Biosciences Holdings, Inc.